The Community Oncology Alliance has warned CMS to expect a possible lawsuit should the agency move forward with the proposed Part B drug cost-control demonstration, previewing its potential legal case in a letter to the agency. Ted Okon, executive director of COA, says the group has tried to be transparent with its concerns so no one should be shocked if the group moves forward with legal action. “Please understand that we are actively pursuing every legal, legislative and related option...